ECJ Confirms Fine on AstraZeneca for Abusing The Patent and Regulatory Systems
Allen & Overy
December 14, 2012
3 pages
Wednesday, Jun 19th
Last update10:42:19 AM
Just in....
Font Size
Profile
Layout
Direction
Menu Style
You are here:
Country/Region 
European Union EU Antitrust & Competition AstraZeneca v. Commission & Abuse of Dominant Position Allen & Overy: ECJ Confirms Fine on AstraZeneca for Abusing The Patent and Regulatory Systems
European Union EU Antitrust & Competition AstraZeneca v. Commission & Abuse of Dominant Position Allen & Overy: ECJ Confirms Fine on AstraZeneca for Abusing The Patent and Regulatory Systems
Trending ..... Bankers' Bonus Cap ..... Cybersecurity Proposals ..... ESMA's AIFMD Remuneration Guidance ..... Financial Transactions Tax ..... Model Leniency Program ..... EU Nearer to European Banking Union ..... UsedSoft: CJEU OKs sale of Used Software Licenses ..... The Eurozone Crisis ..... ESMA Consults on Prospectus Directive ..... New Round(s) of Iran Sanctions .....Apple & E-publishing Giants Under Competition Microscope ..... EC Refreshes Bank State Aid Rules ..... Reform of Data Protection Directive ..... MiFID II ..... EU's MAD Proposal ..... A European Patent? Patent Court? ..... US & EU Sanctions Get Syria-ous ..... Solvency II
EU Menu
 |
|
 |
 |